» Articles » PMID: 15584769

Obsessive-compulsive Disorder in Schizophrenia: Clinical Characteristics and Treatment

Overview
Journal CNS Drugs
Specialties Neurology
Pharmacology
Date 2004 Dec 9
PMID 15584769
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

There is a considerable overlap of schizophrenia and obsessive-compulsive disorder (OCD) in the structural and functional brain abnormalities involved, role of the dopamine/serotonin neurotransmitter systems, and some demographic and clinical characteristics. Although OCD co-occurs in a substantial proportion of schizophrenia patients, a systematic evaluation of the clinical features and treatment of this population is lacking. This review critically evaluates findings of recent studies pertaining to the rate of occurrence of OCD or obsessive-compulsive symptoms (OCS) in schizophrenia and the clinical characterisation of the schizo-obsessive subtype. Specifically, interrelationships between obsessive-compulsive and schizophrenic symptoms in terms of temporal relationships and their association with specific schizophrenia subtypes and the effect of OCS on the severity of schizophrenia symptoms are addressed. In the absence of evidence-based data, tentative therapeutic approaches in this difficult-to-treat patient subgroup are suggested. These include monotherapy with atypical antipsychotic agents or a combination of either typical or atypical antipsychotics with SSRIs or clomipramine. The clinical characteristics of antipsychotic-induced OCS/OCD are also presented to facilitate identification and management of this rare but clinically significant adverse effect. Finally, future directions of research in schizophrenia-OCD comorbidity relevant to clinical practice are discussed.

Citing Articles

Prevalence of obsessive-compulsive symptoms in patients with schizophrenia treated with clozapine: a scoping review.

Moreno Tarazona E, Orozco Gonzalez M, La Rosa Giron A, Ruiz-Grosso P, Lazo-Porras M BMC Psychiatry. 2025; 25(1):71.

PMID: 39849391 PMC: 11759428. DOI: 10.1186/s12888-024-06466-9.


Untangling Depression in Schizophrenia: The Role of Disorganized and Obsessive-Compulsive Symptoms and the Duration of Untreated Psychosis.

Panov G, Dyulgerova S, Panova P, Stefanova S Biomedicines. 2024; 12(11).

PMID: 39595210 PMC: 11592192. DOI: 10.3390/biomedicines12112646.


The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study.

Fernandez-Egea E, Chen S, Sanguesa E, Gasso P, Biria M, Plaistow J Br J Psychiatry. 2024; 224(5):164-169.

PMID: 38652060 PMC: 11039551. DOI: 10.1192/bjp.2024.30.


Disruption of consciousness depends on insight in OCD and on positive symptoms in schizophrenia.

Tumkaya S, Yucens B, Gunduz M, Maheu M, Berkovitch L bioRxiv. 2024; .

PMID: 38293050 PMC: 10827121. DOI: 10.1101/2024.01.02.571832.


The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia.

Vellucci L, Ciccarelli M, Buonaguro E, Fornaro M, DUrso G, De Simone G Biomolecules. 2023; 13(8).

PMID: 37627285 PMC: 10452784. DOI: 10.3390/biom13081220.


References
1.
Alzaid K, Jones B . A case report of risperidone-induced obsessive-compulsive symptoms. J Clin Psychopharmacol. 1997; 17(1):58-9. DOI: 10.1097/00004714-199702000-00014. View

2.
Jonkers F, de Haan L . Olanzapine-induced obsessive-compulsive symptoms in a patient with bipolar II disorder. Psychopharmacology (Berl). 2002; 162(1):87-8. DOI: 10.1007/s00213-002-1062-x. View

3.
Buckley P, Schulz S . Obsessive-compulsive symptoms and clozapine. Br J Psychiatry. 1994; 165(3):408. DOI: 10.1192/bjp.165.3.408a. View

4.
Baker R, Ames D, Umbricht D, Chengappa K, Schooler N . Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo. Psychopharmacol Bull. 1996; 32(1):89-93. View

5.
Eisen J, Rasmussen S . Obsessive compulsive disorder with psychotic features. J Clin Psychiatry. 1993; 54(10):373-9. View